@Article{crph347,
AUTHOR = {Lath, Gunjan and Rhee, Raju and Nikam, Kaveri},
TITLE = {Digital Therapeutics in Oncology: A Better Outlook for Cancer Patients in the Future},
JOURNAL = {Current Research in Public Health},
VOLUME = {2},
YEAR = {2022},
NUMBER = {1},
PAGES = {1-8},
URL = {https://www.scipublications.com/journal/index.php/JAIBD/article/view/347},
ISSN = {2831-5162},
DOI = {10.31586/jaibd.2022.347},
ABSTRACT = {Digital therapeutics (DTx) is an evidence-based treatment that makes use of high-quality software. As many healthcare systems confront increasing expectations for quality results, the need for digital medications is steadily growing in the clinical arena. To ensure that patients are supported during chemotherapy and that needless hospital visits are avoided, digital therapeutics must be integrated into the cancer care pathway. Oncology patients are usually immunocompromised die to their disease and treatment, rendering them more susceptible to infection than the general population. As a result, visiting to a hospital might endanger their health. In addition, when cancer patients and survivors return home after treatment, digital health interventions provide them with the tools they need to manage their illness and its side effects in the privacy of their own homes. Considering the increasing prevalence of cancer patients and the solution that digital therapeutics has to offer in oncology, its future looks promising. This review article aims to summarize the existing companies in this domain, while evaluating the prospects as well.},
}

%0 Journal Article
%A Lath, Gunjan
%A Rhee, Raju
%A Nikam, Kaveri
%D 2022
%J Current Research in Public Health

%@ 2831-5162
%V 2
%N 1
%P 1-8

%T Digital Therapeutics in Oncology: A Better Outlook for Cancer Patients in the Future
%M doi:10.31586/jaibd.2022.347
%U https://www.scipublications.com/journal/index.php/JAIBD/article/view/347

TY  - JOUR
AU  - Lath, Gunjan
AU  - Rhee, Raju
AU  - Nikam, Kaveri
TI  - Digital Therapeutics in Oncology: A Better Outlook for Cancer Patients in the Future
T2  - Current Research in Public Health
PY  - 2022
VL  - 2
IS  - 1
SN  - 2831-5162
SP  - 1
EP  - 8
UR  - https://www.scipublications.com/journal/index.php/JAIBD/article/view/347
AB  - Digital therapeutics (DTx) is an evidence-based treatment that makes use of high-quality software. As many healthcare systems confront increasing expectations for quality results, the need for digital medications is steadily growing in the clinical arena. To ensure that patients are supported during chemotherapy and that needless hospital visits are avoided, digital therapeutics must be integrated into the cancer care pathway. Oncology patients are usually immunocompromised die to their disease and treatment, rendering them more susceptible to infection than the general population. As a result, visiting to a hospital might endanger their health. In addition, when cancer patients and survivors return home after treatment, digital health interventions provide them with the tools they need to manage their illness and its side effects in the privacy of their own homes. Considering the increasing prevalence of cancer patients and the solution that digital therapeutics has to offer in oncology, its future looks promising. This review article aims to summarize the existing companies in this domain, while evaluating the prospects as well.
DO  - Digital Therapeutics in Oncology: A Better Outlook for Cancer Patients in the Future
TI  - 10.31586/jaibd.2022.347
ER  -